Breathe Well Live Well
 MinnPost.com (blog) |
Advair misused: Article describes troubling details of the overselling of an …
MinnPost.com (blog) The drug in this case is Advair, which is used by millions of people with asthma, a chronic inflammatory disease that causes the airways to become inflamed and constricted, leading to wheezing, coughing and difficulty breathing. Although asthma is … |
View full post on asthma – Google News
 eMaxHealth |
Asthma Drug Advair Safety Questioned
eMaxHealth If you or your children have asthma, it's very likely you have been prescribed Advair (fluticasone/salmeterol), the largest selling asthma drug in the United States. But don't let the attractive, brightly colored purple packaging detract you from this … Daily Rounds: Risky Asthma Drug; Obamacare Unknowns; Boys' Body Image … |
View full post on asthma – Google News
 MedPage Today |
Advair: How Safe Is This Drug?
MedPage Today The 2001 product launch of the asthma drug Advair (fluticasone/salmeterol) was a lavish, Las Vegas affair. Using images of a slot machine to illustrate their message, top GlaxoSmithKline executives took the stage in front of thousands of assembled … 1990s trial gave early danger signs for asthma drugs |
View full post on asthma – Google News
 Wall Street Journal |
Glaxo Tries to Shake Marketing Questions on Advair
Wall Street Journal GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair. Glaxo Executives Cited in Case Now Lead Sanofi, Actelion WSJ: Glaxo Tries to Shake Marketing Questions Ex-Glaxo execs in U.S. case now lead other drugmakers |
View full post on asthma – Google News
|
Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being Used
AIDSmeds.com HIV/AIDS Treatment News by Tim Horn Good news for people living with HIV and asthma, bronchitis and chronic obstructive pulmonary disease (COPD). The inhalable steroid beclomethasone can be used at the same time as HIV protease inhibitors without the increased risk of adrenal … |
View full post on asthma – Google News
 Southeast Texas Record |
Woman's suit blames Advair for son's near fatal asthma attack
Southeast Texas Record GALVESTON – TeAna Anthony is suing Glaxosmithkine LLC after her minor son experienced a near fatal episode after taking one of its medications for his asthma. According to a lawsuit filed Jan. 19 in Galveston County Court at Law No. |
View full post on asthma – Google News
|
Nycomed and Orion to sell generic Advair and Symbicort
Pharma Times The firms have signed an agreement which covers Orion's combination products for the treatment of asthma and chronic obstructive pulmonary disease, delivered by its new Easyhaler dry powder inhaler. In particular, Orion is developing copies of GSK's … Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPD |
View full post on asthma – Google News
|
Exclusive – Glaxo R&D boss says Advair safe from generic
Reuters UK L) $8 billion (5 billion pounds)-a-year Advair treatment for asthma and smoker's cough can hope to capture only "a very small fraction" of its sales, the British drugmaker's research chief said on Tuesday. Advair, an inhaler which delivers two drugs … |
View full post on asthma – Google News
|
Exclusive – Glaxo R&D boss says Advair safe from generics
Reuters UK L) $8 billion (5 billion pounds)-a-year Advair treatment for asthma and smoker's cough can hope to capture only "a very small fraction" of its sales, the British drugmaker's research chief said on Tuesday. Advair, which uses an inhaler to deliver two … |
View full post on asthma – Google News
|
GSK sees positive results on asthma, COPD drug expected to succeed Advair
MedCity News The results boost the compound's prospects as a successor to GSK's blockbuster asthma and COPD drug Advair, whose patents have expired. London-based GSK, which maintains its US headquarters in Research Triangle Park, North Carolina, and drug partner … GSK gets good news on asthma drug Glaxo Drug Gets Positive Trial Results Theravance, Glaxo Lung Drug Passes Two Pivotal Trials; Two More to Go |
View full post on asthma – Google News